Title : Chair to bedside: Translational advances in salivary biomarker analysis
Abstract:
Saliva has emerged as a promising diagnostic biofluid, offering a non-invasive, cost-effective, and patient-friendly alternative to blood-based investigations. The concept of “from chair to bedside” underscores the translational journey of salivary biomarker research—from laboratory discovery to routine bedside clinical application. This lecture aims to highlight recent translational advances in salivary biomarkers and their growing relevance in clinical decision-making across medical and dental disciplines.
Advances in molecular biology, proteomics, genomics, metabolomics, and nanotechnology have significantly expanded the diagnostic potential of saliva. A wide array of salivary biomarkers, including proteins, nucleic acids, hormones, antibodies, and microbial signatures, have demonstrated strong correlations with local and systemic diseases. These biomarkers have shown promise in the early detection, prognosis, and monitoring of conditions such as oral cancer, periodontal diseases, diabetes mellitus, cardiovascular disorders, autoimmune diseases, and viral infections. The development of highly sensitive analytical platforms and point-of-care devices has further accelerated the translation of salivary diagnostics into chairside and bedside settings.
This lecture will discuss the biological basis of saliva as a diagnostic medium, key milestones in biomarker discovery, and validation strategies essential for clinical translation. Emphasis will be placed on real-world applications, including chairside screening tools, personalized medicine, and disease monitoring, as well as the integration of salivary diagnostics into routine clinical workflows. A comprehensive approach with different clinical studies, done by author will be discussed.


